GLP1R and type 2 diabetes mellitus: In fact, improved mitochondrial oxidative stress and biogenesis-related pathways are shared processes with other T2D drugs, such as glucagon-like 1 peptide receptor agonists (GLP-1RA), and both warrant further mechanistic research [49,50].